课题基金 / 基金详情

Differentiation-inducing signals in osteoblasts and its application for development of bone anabolic therapy

Differentiation-inducing signals in osteoblasts and its application for development of bone anabolic therapy
成骨细胞分化诱导信号及其在骨合成代谢治疗中的应用
批准号:
14370329
负责人:
MATSUMOTO Toshio
金额:
$8.83万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2004

项目摘要

项目成果

MATSUMOTO Toshio的其他基金

相似基金

相关文献

中文摘要
翻译
(1)AP-1/IL-11信号通路的分析1. fosB/deltafosB基因的转录诱导体外流体剪切力(FSS)诱导成骨细胞表达deltafosB,这是一种AP-1家族转录因子,当在转基因小鼠中过度表达时能够刺激体内骨形成。进一步的机制研究表明,FSS促进fosB/deltafosB基因转录的方式依赖于钙离子、ERK和CREB,而CREB通过存在于小鼠fosB基因上游调控区的CRE-like序列起作用。2. AP-1和SmadsSmall之间的串扰是一种转录因子,作用于BMP-2的下游,BMP-2是一种众所周知的骨形成诱导剂。我们发现FSS激活的AP-1与Smad 1在物理上相互作用并在功能上协同诱导IL-11基因的转录。(2)IL-11在糖皮质激素诱导的骨质疏松症(GIO)中的致病作用1. IL-11 PTH和IL-11的抗凋亡作用可使地塞米松和足叶乙甙诱导的成骨细胞凋亡抑制50%。Bcl-2的表达,抗凋亡因子,下调这些凋亡诱导剂,这是由PTH或IL-11恢复。PTH对IL-11基因转录的抑制可诱导IL-11基因的转录,这种诱导作用可被地塞米松阻断。我们发现,这些作用都在很大程度上依赖于IL-11启动子中的AP-1结合位点。这些结果表明,IL-11在地塞米松的促凋亡作用和PTH的抗凋亡作用中均起作用。
英文摘要
(1)Analysis of the AP-1/IL-11 signaling pathway1.Transcriptional induction of fosB/deltafosB geneFluid shear stress (FSS) in vitro induced osteoblast expression of deltafosB, an AP-1 family transcription factor that is able to stimulate bone formation in vivo when over-expressed in transgenic mice. Further mechanistic studies revealed that FSS promoted fosB/deltafosB gene transcription in a manner dependent on calcium, ERK, and CREB, which acted via CRE-like sequences present in the mouse fosB gene upstream regulatory region.2.Crosstalk between AP-1 and SmadsSmall is a transcription factor that act downstream of BMP-2, a well-known inducer of bone formation. We found that FSS-activated AP-1 physically interacted and functionally cooperated with Smad1 to induce interleukin (IL)-11 gene transcription.(2)Pathogenic roles of IL-11 in glucocorticoid-induced osteoporosis (GIO)1.Anti-apoptotic effects of IL-11PTH as well as IL-11 suppressed dexamethasone- and etoposide-induced osteoblast apoptosis by 50 %. Expression of Bcl-2, an anti-apoptotic factor, was down-regulated by these apoptosis inducers, which was restored by PTH or IL-11. And the effect of PTH was partially blocked by an anti-IL-11 neutralizing antibody2.Transcriptional repression of IL-11 gene by dexamethasonePTH induced IL-11 gene transcription, and this induction was blocked by dexamethasone. We found that these effects were both largely dependent on the AP-1 binding site in the IL-11 promoter.Collectively, these results suggest that IL-11 plays a role in both pro-apoptotic effects of dexamethasone and anti-apoptotic effects of PTH in osteoblasts.
期刊论文(112)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1074/jbc.m404865200
发表时间: 2004-08-20
期刊: JOURNAL OF BIOLOGICAL CHEMISTRY
影响因子: 4.8
作者: [Aihara, K, Azuma, H, Matsumoto, T]
通讯作者: Matsumoto, T
Tohjima E, et al.: "Decreased AP-1 activity and interleukin-11 expression by bone marrow stromal cells may be associated with impaired bone formation in aged mice"Journal of Bone and Mineral Research. 18. 1461-1470 (2003)
Tohjima E 等人:“骨髓基质细胞 AP-1 活性和白细胞介素 11 表达的降低可能与老年小鼠骨形成受损有关”《骨与矿物质研究杂志》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kitagawa H, et al.: "Ligand selective potentiation of rat mineralocorticoid receptor activation function-1 (AF-1) by a CBP-containing HAT complex"Mol Cell Biol. 22. 3698-3706 (2002)
Kitakawa H 等人:“含有 CBP 的 HAT 复合物对大鼠盐皮质激素受体激活功能 1 (AF-1) 的配体选择性增强”Mol Cell Biol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kido S, et al.: "RANK is Dependent upon Differentiation into the Macrophage/Osteoclast Lineage : Induction by 1alpha, 25-dihydroxyvitamin D3 and TPA in a Human Myelomonocytic Cell Line, HL60"BONE. (印刷中). (2003)
Kido S 等人:“RANK 取决于巨噬细胞/破骨细胞谱系的分化:在人骨髓单核细胞系 HL60 中通过 1α、25-二羟基维生素 D3 和 TPA 进行诱导”(出版中)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 33 条
    Role and mechanism of action of IL-11 on the regulation of bone and adipose tissue interaction
    • 批准号:
      16H05327
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.15万
    • 财政年份:
      2016
    • 负责人:
      MATSUMOTO Toshio
    • 依托单位:
    Elucidation of molecular mechanism of the regulation of skeletal homeostasis, and development of new therapeutic approaches against skeletal disorders
    • 批准号:
      25293215
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.81万
    • 财政年份:
      2013
    • 负责人:
      MATSUMOTO Toshio
    • 依托单位:
    Relationships among skeletal, adipose and vasclar regulatory system, and elucidation of pathogensis caused by disturbances of these systems
    • 批准号:
      20249050
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $30.7万
    • 财政年份:
      2008
    • 负责人:
      MATSUMOTO Toshio
    • 依托单位:
    Observational study of the first stars of the Universe
    • 批准号:
      18204018
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $22.46万
    • 财政年份:
      2006
    • 负责人:
      MATSUMOTO Toshio
    • 依托单位:
    国内基金
    海外基金
    Foxc2介导Syap1/Akt信号通路调控破骨/成骨细胞分化促进颞下颌关节骨关节炎的机制研究
    • 批准号:
      82370979
    • 项目类别:
      面上项目
    • 资助金额:
      48.00万元
    • 批准年份:
      2023
    • 负责人:
      张善勇
    • 依托单位:
    仿生膜构建破骨细胞融合纳米诱饵用于骨质疏松治疗的研究
    • 批准号:
      82372098
    • 项目类别:
      面上项目
    • 资助金额:
      48.00万元
    • 批准年份:
      2023
    • 负责人:
      倪大龙
    • 依托单位:
    组蛋白乙酰化修饰ATG13激活自噬在牵张应力介导骨缝Gli1+干细胞成骨中的机制研究
    • 批准号:
      82370988
    • 项目类别:
      面上项目
    • 资助金额:
      48.00万元
    • 批准年份:
      2023
    • 负责人:
      经典
    • 依托单位:
    先天型成骨不全骨量失衡的病理机制及动物模型的研究
    • 批准号:
      30973070
    • 项目类别:
      面上项目
    • 资助金额:
      33.0万元
    • 批准年份:
      2009
    • 负责人:
      张浩
    • 依托单位: